Stocks›Healthcare›BAX

BAX Baxter International Inc.

NYSEResearch view

Baxter International Inc. operates in the Surgical & Medical Instruments & Apparatus industry.

$25.28−1.86%
Oct 16 close · 1D EOD · Databento
HealthcareSurgical & Medical Instruments & ApparatusLarge-capSEC EDGAR FY 2025-12-31

On the WireNo stories on BAX yet. Follow the company and the next one lands in Following.

The numbers · FY2025, filed

SEC EDGAR
Market cap$13.1B
Revenue$11.2B+5.70%
Net income$-957.0M
EPS, diluted$-1.87−47.20%
Gross margin30.1%
Operating margin-2.7%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$13.1B
Enterprise Value$20.5B
Income$-957.0M
Sales$11.2B
Book/sh$11.80
Cash/sh$3.81
Dividend TTM$0.52
Payout-36%
Employees—
IPO—
Quick Ratio1.56
Current Ratio2.31
Debt/Eq1.55
EPS (ttm)$-1.87
EPS this Y-47.2%
EPS past 3/5Y—
Sales past 3/5Y3.8%
EPS Y/Y TTM-47.2%
Sales Y/Y TTM5.7%
Shs Outstand517.00M
ROA-4.8%
ROE-15.7%
ROIC-4.0%
Gross Margin30.1%
Oper. Margin-2.7%
Profit Margin-8.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$12.1B
FY21
$10.1B
FY22
$10.4B
FY23
$10.6B
FY24
$11.2B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%30%-3%-9%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.